Microbot Medical (MBOT) Free Cash Flow (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Free Cash Flow data on file, last reported at -$5.2 million in Q1 2026.

• Quarterly Free Cash Flow fell 78.77% year-over-year to -$5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.4 million (down 65.29% YoY) and the FY2025 annual result came in at -$13.1 million, down 48.06% from the prior year.
• Free Cash Flow declined to -$5.2 million in Q1 2026, from -$3.8 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$1.7 million in Q3 2023 to a low of -$5.2 million in Q1 2026.
• A 5-year average of -$2.8 million and a median of -$2.8 million in 2024 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2023 — Free Cash Flow surged 43.14% — and 2025, when it plunged 122.79%.
• Tracing MBOT's Free Cash Flow over 5 years: stood at -$2.5 million in 2022, then rose by 26.3% to -$1.8 million in 2023, then gained by 6.5% to -$1.7 million in 2024, then tumbled by 122.79% to -$3.8 million in 2025, then tumbled by 36.43% to -$5.2 million in 2026.
• The last three Free Cash Flow figures came in at -$5.2 million (Q1 2026), -$3.8 million (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.